Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $1.36 Million - $2.13 Million
18,790 New
18,790 $1.36 Million
Q3 2021

Nov 10, 2021

SELL
$109.17 - $142.35 $480,348 - $626,340
-4,400 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$100.34 - $115.69 $98,734 - $113,838
984 Added 28.81%
4,400 $476,000
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $131,963 - $162,851
1,300 Added 61.44%
3,416 $360,000
Q4 2020

Feb 09, 2021

SELL
$85.88 - $105.36 $188,936 - $231,792
-2,200 Reduced 50.97%
2,116 $220,000
Q3 2020

Oct 15, 2020

SELL
$72.74 - $92.5 $38,552 - $49,025
-530 Reduced 10.94%
4,316 $370,000
Q2 2020

Jul 29, 2020

BUY
$48.02 - $79.04 $232,704 - $383,027
4,846 New
4,846 $355,000
Q1 2020

Apr 29, 2020

SELL
$36.95 - $62.95 $177,212 - $301,908
-4,796 Closed
0 $0
Q4 2019

Jan 23, 2020

SELL
$47.06 - $56.64 $201,510 - $242,532
-4,282 Reduced 47.17%
4,796 $270,000
Q3 2019

Oct 16, 2019

BUY
$47.45 - $58.05 $68,897 - $84,288
1,452 Added 19.04%
9,078 $433,000
Q2 2019

Jul 10, 2019

BUY
$39.26 - $54.21 $299,396 - $413,405
7,626 New
7,626 $413,000
Q4 2018

Feb 08, 2019

SELL
$29.95 - $46.34 $270,418 - $418,403
-9,029 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$40.12 - $45.55 $64,191 - $72,880
-1,600 Reduced 15.05%
9,029 $411,000
Q2 2018

Jul 13, 2018

BUY
$38.72 - $42.52 $3,872 - $4,252
100 Added 0.95%
10,629 $445,000
Q1 2018

May 04, 2018

BUY
$39.4 - $47.39 $216,700 - $260,645
5,500 Added 109.37%
10,529 $432,000
Q4 2017

Feb 14, 2018

SELL
$37.27 - $43.02 $43,643 - $50,376
-1,171 Reduced 18.89%
5,029 $207,000
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $209,250 - $258,354
6,200
6,200 $248,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.